LABCORP HOLDINGS INC. vs NATERA, INC., two Medical Diagnostics stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where LH and NTRA diverge most: on operating margin, LH reads 12.1% and NTRA reads -10.1%; on net margin, LH reads 7.0% and NTRA reads -7.1%. The rest of the comparable metrics sit closer together. What LH's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | LH | NTRA |
|---|---|---|
| Price | $312.14 | $400.47 |
| Market cap | $25.6B | $57.4B |
| Sector | Medical Diagnostics | Medical Diagnostics |
| Stage | Mature | Growth |
| Implied growth (priced in) | +4.0% | — |
| P/E | 25.8 | — |
| P/B | 2.97 | 31.50 |
| P/S | 1.78 | 21.20 |
| EV/EBITDA | 16.6 | — |
| Revenue growth | +6.4% | +37.8% |
| Gross margin | 29.8% | — |
| Operating margin | 12.1% | -10.1% |
| Net margin | 7.0% | -7.1% |
| Return on equity | 11.7% | -10.6% |
| Return on assets | 5.4% | -7.2% |
| Return on invested capital | 8.2% | -11.1% |
| FCF yield | 4.5% | 0.1% |
| Dividend yield | 0.9% | — |
| Debt / equity | 0.68 | 0.04 |
| Current ratio | 1.80 | 3.00 |
| Altman Z (solvency) | 3.17 | 5.88 |
| Piotroski F (quality) | 7 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.